We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
6 peer-reviewed studies
What the evidence says
Most Goji Berries studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 2012–2023.
Based on 6 studies · 3 meta-analyses
Confidence
HighBy outcome
3 studies in the last 5 years · Latest meta-analysis: 2023
A meta-analysis found wolfberry (goji) consumption was associated with reduced cardiovascular disease risk markers.
Toh DWK et al. · European journal of nutrition (2022)
A meta-analysis found Lycium barbarum supplementation improved the lipid profile.
Zeng X et al. · Medicine (2023)
A systematic review summarized therapeutic uses of Lycium barbarum, including eye and metabolic health.
Kwok SS et al. · BioMed research international (2019)
A meta-analysis reported goji improved general feelings of well-being.
Paul Hsu CH et al. · Journal of medicinal food (2012)
An evidence-based review (Natural Standard) summarized goji's traditional uses and clinical evidence.
Ulbricht C et al. · Journal of dietary supplements (2015)
A review examined Lycium barbarum polysaccharides in ageing and potential macular/eye use.
Ni J et al. · BMC complementary medicine and therapies (2021)